NO20083709L - Nye krystallinske forbindelser - Google Patents

Nye krystallinske forbindelser

Info

Publication number: NO20083709L
Authority: NO; Norway
Prior art keywords: acid; crystalline compounds; naphthalene; new crystalline; tartaric
Prior art date: 2006-04-13

Application number

NO20083709A

Other languages

English (en)

Norwegian (no)

Inventor

Ulrike Werthmann

Uwe Ries

Sonja Sproll

Andreas Zopf

Guenther Huchler

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-04-13

Filing date

2008-08-28

Publication date

2008-10-31

2008-08-28 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2008-10-31 Publication of NO20083709L publication Critical patent/NO20083709L/no

Links

150000001875 compounds Chemical class 0.000 title abstract 2
239000002253 acid Substances 0.000 abstract 3
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract 2
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 2
150000007513 acids Chemical class 0.000 abstract 2
XTEGVFVZDVNBPF-UHFFFAOYSA-N naphthalene-1,5-disulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 abstract 2
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 abstract 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 2
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 1
239000001358 L(+)-tartaric acid Substances 0.000 abstract 1
235000011002 L(+)-tartaric acid Nutrition 0.000 abstract 1
FEWJPZIEWOKRBE-LWMBPPNESA-N L-(+)-Tartaric acid Natural products OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 abstract 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 abstract 1
229940092714 benzenesulfonic acid Drugs 0.000 abstract 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 abstract 1
239000001530 fumaric acid Substances 0.000 abstract 1
150000004677 hydrates Chemical class 0.000 abstract 1
AUONNNVJUCSETH-UHFFFAOYSA-N icosanoyl icosanoate Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCCCCCCCC AUONNNVJUCSETH-UHFFFAOYSA-N 0.000 abstract 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
239000011976 maleic acid Substances 0.000 abstract 1
KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Neurology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Addiction (AREA)
Cardiology (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Pregnancy & Childbirth (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Obesity (AREA)
Gynecology & Obstetrics (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Otolaryngology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Physical Education & Sports Medicine (AREA)

NO20083709A 2006-04-13 2008-08-28 Nye krystallinske forbindelser NO20083709L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102006017827A DE102006017827A1 (de)	2006-04-13	2006-04-13	Neue kristalline Verbindungen
PCT/EP2007/053488 WO2007118819A2 (de)	2006-04-13	2007-04-11	Neue kristalline verbindungen

Publications (1)

Publication Number	Publication Date
NO20083709L true NO20083709L (no)	2008-10-31

Family

ID=38514672

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20083709A NO20083709L (no)	2006-04-13	2008-08-28	Nye krystallinske forbindelser

Country Status (20)

Country	Link
US (1)	US7638625B2 (es)
EP (1)	EP2010513A2 (es)
JP (1)	JP2009533387A (es)
KR (1)	KR20090007428A (es)
CN (1)	CN101421263A (es)
AR (1)	AR060442A1 (es)
AU (1)	AU2007239505A1 (es)
BR (1)	BRPI0710151A2 (es)
CA (1)	CA2648140A1 (es)
CO (1)	CO6140057A2 (es)
DE (1)	DE102006017827A1 (es)
EA (1)	EA200802049A1 (es)
EC (1)	ECSP088737A (es)
MX (1)	MX2008013158A (es)
NO (1)	NO20083709L (es)
PE (1)	PE20080735A1 (es)
TW (1)	TW200808767A (es)
UY (1)	UY30280A1 (es)
WO (1)	WO2007118819A2 (es)
ZA (1)	ZA200806859B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7491717B2 (en) *	2005-03-23	2009-02-17	Boehringer Ingelheim International Gmbh	Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
CA2654048A1 (en) *	2006-06-08	2007-12-13	Boehringer Ingelheim International Gmbh	Treatment of gastrointestinal disorders with cgrp antagonists
HRP20171620T1 (hr) *	2012-02-27	2017-12-01	Bristol-Myers Squibb Company	N- (5s, 6s, 9r) - 5 amino- 6 - (2, 3 - difluorofenil) -6, 7, 8, 9 - tetrahidro - 5h - ciklohepta [b]piridin-9 -il- 4 - (2 - okso-2, 3 - dihidro - 1h - imidazo [4, 5 -b]piridin - 1 - il) piperidin - 1 - karboksilat, hemisulfatna sol
US12521389B2 (en) *	2019-06-14	2026-01-13	The Regents Of The University Of California	Therapeutic approach to lung disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU721035C (en) *	1996-09-10	2004-09-02	Dr. Karl Thomae Gmbh	Modified aminoacids, pharmaceuticals containing these compounds and method for their production
DE10250080A1 (de) *	2002-10-25	2004-05-13	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10250082A1 (de) *	2002-10-25	2004-05-13	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102004015723A1 (de) *	2004-03-29	2005-10-20	Boehringer Ingelheim Pharma	Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel

2006
- 2006-04-13 DE DE102006017827A patent/DE102006017827A1/de not_active Withdrawn
2007
- 2007-04-11 CN CNA200780012808XA patent/CN101421263A/zh active Pending
- 2007-04-11 WO PCT/EP2007/053488 patent/WO2007118819A2/de not_active Ceased
- 2007-04-11 EP EP07727956A patent/EP2010513A2/de not_active Ceased
- 2007-04-11 CA CA002648140A patent/CA2648140A1/en not_active Abandoned
- 2007-04-11 EA EA200802049A patent/EA200802049A1/ru unknown
- 2007-04-11 JP JP2009504732A patent/JP2009533387A/ja active Pending
- 2007-04-11 AU AU2007239505A patent/AU2007239505A1/en not_active Abandoned
- 2007-04-11 PE PE2007000446A patent/PE20080735A1/es not_active Application Discontinuation
- 2007-04-11 KR KR1020087027714A patent/KR20090007428A/ko not_active Withdrawn
- 2007-04-11 MX MX2008013158A patent/MX2008013158A/es active IP Right Grant
- 2007-04-11 BR BRPI0710151-1A patent/BRPI0710151A2/pt not_active IP Right Cessation
- 2007-04-12 UY UY30280A patent/UY30280A1/es not_active Application Discontinuation
- 2007-04-12 TW TW096112795A patent/TW200808767A/zh unknown
- 2007-04-12 US US11/734,520 patent/US7638625B2/en active Active
- 2007-04-13 AR ARP070101573A patent/AR060442A1/es unknown
2008
- 2008-08-08 ZA ZA200806859A patent/ZA200806859B/xx unknown
- 2008-08-28 NO NO20083709A patent/NO20083709L/no not_active Application Discontinuation
- 2008-09-15 EC EC2008008737A patent/ECSP088737A/es unknown
- 2008-10-10 CO CO08108825A patent/CO6140057A2/es unknown

Also Published As

Publication number	Publication date
US7638625B2 (en)	2009-12-29
PE20080735A1 (es)	2008-07-25
ZA200806859B (en)	2009-08-26
WO2007118819A3 (de)	2008-05-29
KR20090007428A (ko)	2009-01-16
AR060442A1 (es)	2008-06-18
MX2008013158A (es)	2008-10-22
AU2007239505A1 (en)	2007-10-25
TW200808767A (en)	2008-02-16
EP2010513A2 (de)	2009-01-07
JP2009533387A (ja)	2009-09-17
BRPI0710151A2 (pt)	2011-08-02
CN101421263A (zh)	2009-04-29
US20080086003A1 (en)	2008-04-10
EA200802049A1 (ru)	2009-04-28
WO2007118819A2 (de)	2007-10-25
DE102006017827A1 (de)	2007-10-18
UY30280A1 (es)	2007-11-30
CO6140057A2 (es)	2010-03-19
ECSP088737A (es)	2008-10-31
CA2648140A1 (en)	2007-10-25

Legal Events

Date	Code	Title	Description
2011-11-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
MX2010006179A (es)	2010-08-04	Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico.
PH12012500519A1 (en)	2012-10-22	Substituted carbamoylmethylamino acetic acid derivatives as novel nep inhibitors
NO20073720L (no)	2007-11-05	Heterocyklisk substituerte fenylmetanoner som inhibitorer av glycintransportorer
WO2008055013A3 (en)	2009-01-22	5-oxo-5,8 - dihydro - pyrido - pyrimidines as inhibitors of c-fms kinase
NO20091782L (no)	2009-06-10	Fremgangsmate for syntese av derivater av 3-amino-tetrahydrofuran-3-karboxylsyre og deres anvendelse som medikamenter
NZ597538A (en)	2014-05-30	Regioselective preparation of 2 -amino-5-trifluoromethylpyrimidine derivatives
WO2007118819A3 (de)	2008-05-29	Neue kristalline verbindungen
ATE529181T1 (de)	2011-11-15	Neuartiges dispersionsmittel und zusammensetzungen daraus
WO2008087654A3 (en)	2008-12-18	PIPERIDINES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1
GEP20084494B (en)	2008-09-25	New heterocyclic carboxylic acid amide derivatives
NO20072755L (no)	2007-07-02	Fremgangsmate for fremstilling av 4-(6-klor-2-metylendioksyanilino)-7-2-(4-metylpiperazin-1-yl)etoksy]-5-tetrahydropyran-4-yloksykinazolin, deres mellomprodukter og krystallinske salter derav
WO2007017728A3 (en)	2008-04-03	Novel heterocyclic compounds
Annedi et al.	2012	3, 5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors
MX2010009926A (es)	2010-09-28	Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
WO2007105021A3 (en)	2007-11-22	Duloxetine salts
NO20070845L (no)	2007-11-02	Fremgangsmate for fremstilling av losartan
CY1112979T1 (el)	2016-04-13	Διαδικασια για την παρασκευη της ενωσης (s)-1-αλκυλ-2',6'-πιπεκολοξυλιδιδιου
WO2007135693A3 (en)	2009-06-11	Intermediates useful for the preparation of antihistaminic piperidine derivative
NO20070776L (no)	2007-04-11	Forbedret prosess for fremstilling av mirtazapin
NO20060258L (no)	2006-01-18	Nematicidale tiazolin-inneholdende fluorobutener
Imaeda et al.	2008	Discovery of sulfonylalkylamides: A new class of orally active factor Xa inhibitors
DE602006007483D1 (es)	2009-08-06
WO2010012797A3 (en)	2010-04-22	Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives
IL194392A0 (en)	2009-08-03	Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists
WO2007004041A3 (en)	2007-03-22	New compounds and their pharmaceutical use